Publications

Spithoff, S., McPhail, B., Vesley, L., Rowe, R.K., Mogic, L. & Grundy, Q. (2024) How the virtual care industry gathers, uses and values patient data: a Canadian qualitative study. BMJ Open, 14, e074019. doi: 10.1136/bmjopen-2023-074019.

Gorodensky, A., Grundy, Q., Persaud, N. & Kohler, J. (2023). Shared health governance, mutual collective accountability, and transparency in COVAX: A qualitative study triangulating data from document sampling and key informant interviews. Journal of Global Health, 13, 04165, doi: 10.7189/jogh.13.04165.

Grundy, Q., Held, F., Hart, D., Baugh, C.M., Ladd, E., Campbell, E., & Bero, L. (2023). Characteristics of advanced practice nurses receiving top industry payments and their practice settings: A cross-sectional study. J General Internal Medicine. doi: 10.1007/s11606-023-08508-6

Grundy, Q., Quanbury, A., Hart, D., Chaudhry, S., Tavangar, F., Lexchin, J., Gagnon, MA., & Tadrous, M. (2023). The prevalence and characteristics of pharmaceutical industry patient support programs for prescription medicines: A cross-sectional study. CMAJ, 195(46): E1565-E1576. doi: 10.1503/cmaj.230841

Pimienta, J., Bethe, T., Brandt, J., Holz, R., Continella, A., Jibb, L., & Grundy, Q. (2023). Mobile apps and children’s privacy: A traffic analysis of data sharing practices among children’s mobile iOS apps. Archives of Disease in Childhood.

Owadally, T., & Grundy, Q. From a criminal to a human-rights issue: Re-imagining policy solutions to homelessness. Policy, Politics, & Nursing Practice. 2023;0(0). doi:10.1177/15271544231176255

Grundy, Q., Hart, D., Perkins-Meingast, B., Heesters, A. & Miller, F. (2023). Outsourcing practice-based education: The role of industry representatives and implications for clinical expertise. Healthcare Management Forum. doi: 10.1177/08404704231173552.

Spithoff, S., & Grundy, Q. (2023). Commercializing personal health information: A critical qualitative content analysis of documents describing proprietary care databases in Canada. International Journal of Health Policy and Management, 12(1), 1-11. doi: 10.34172/ijhpm.2023.6938.

Grundy, Q., Campbell, C., Ali, R., Herder, M. & Holloway, K. (in press). ‘A most equitable drug’: How clinical studies of convalescent plasma against SARS-CoV-2 might usefully inform post-pandemic public sector clinical trials for drug development. J Law Med Ethics. Available at SSRN: https://ssrn.com/abstract=4322653

Gamage, K., Chiu, K., Ryk, J., Grundy, Q., Sud, A. (2023). How policy problems and solutions travel in the scientific literature: An international scientometric analysis of the French Model of opioid use disorder care. J Evaluation in Clinical Practice, 29(4), 576-590. doi: 10.1111/jep.13822. 

Grundy, Q., Imahori, D., Mahajan, S., Timothy, R., Garner, G., Sud, A., Soklaridis, S. & Buchman, D.Z. (2023). Cannabis companies and the sponsorship of scientific research: A cross-sectional Canadian case study. PLoS ONE, 18(1): e0280110. doi:10.1371/journal.pone.0280110.

Grundy, Q., Davenport Huyer, L., Parker, L. & Bero, L. (2022). Branded care: The policy implications of pharmaceutical industry-funded nursing care related to specialty medicines. Policy, Politics, and Nursing Practice. doi: 10.1177/15271544221121749

Sud, A., Strang, M., Buchman, D., Spithoff, S., Webster, F., Upshur, R. & Grundy, Q. (2022). Dispensing education: Pharmaceutical industry promotion of Suboxone® during the opioid crisis. BMJ Open, 12(7): e059561

Holloway, K., Campbell, C., Ali, R., Davenport Huyer, L., Hart, D., Haw, J., Brennenstuhl, S. & Grundy, Q. (2022). A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors. Transfusion Medicine, 32(5), 351-365. doi:10.1111/tme.12875.

Blakely, B., Rogers, W., Johnson, J., Grundy, Q., Hutchison, K., Clay-Williams, R., Richards, B. and Maddern, G. (2022). Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives. BMC Med Ethics 23, 31. doi: 10.1186/s12910-022-00771-2.

Grundy, Q., Parker, L., Wong, A., Fusire, T., Dimancesco, D., Tisocki, K., Walkowiak, H., Vian, T. & Kohler, J. (2022). Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region. Globalization & Health 18, 33 (2022). doi: 10.1186/s12992-022-00822-8

Jibb, L., Amoako, E., Heisey, M., Ren, L., & Grundy, Q. (2022). Data handling practices and commercial features of apps related to children: a scoping review of content analyses. Archives of Disease in Childhood. doi: 10.1136/archdischild-2021-323292

Grundy, Q, & Parker, L. (2022). Conflict of interest management policies and practices in the public pharmaceutical sector in South-East Asia Region. New Delhi, India: World Health Organization South-East Asia Region Office (SEARO).

Grundy, Q., Millington, A., Robinson, A., Held, F. & Fabbri, A. (2022). Exposure, access and interaction: A global analysis of sponsorship of nursing professional associations. J Advanced Nursing, 78(4), 1140-1153. doi: 10.1111/jan.15158

Persaud, N., Ally, M., Woods, W., Workentin, A., Baxter, N.N., Boozary, A., Grundy, Q., Lofters, A., McKenzie, K., Pinto, A., Schünemann, H.J., & Straus, S. (2022). Inclusion of racialised people in clinical practice guideline panels: cross-sectional study. The Lancet. doi: 10.1016/S0140-6736(21)02759-8

Grundy, Q. (2022). A review of the impact and quality of mobile health apps. Annual Review of Public Health, 43. doi: 10.1146/annurev-publhealth-052020-103738.

Bero, L., Lawrence, R. Leslie, L., Chiu, K.,* McDonald, S.,* Page, M.J., Grundy, Q., Parker, L., Boughton, S.L., Kirkham, J.J. & Featherstone, R. (2021). Comparison of preprints and final journal publications from COVID-19 studies: Discrepancies in results reporting and spin in interpretation. BMJ Open, 11: e051821. doi:10.1136/ bmjopen-2021-051821.

Grundy, Q., Jibb, L., Amoako, E. & Fang, G. (2021). Health apps are designed to track and share. BMJ, 373, n1429. doi: 10.1136/bmj.n1429.

Grundy, Q. (2021). A politics of objectivity: Evidence-based medicine’s attempts to grapple with “non-financial” conflicts of interest. Science and Engineering Ethics, 27(3):37. doi: 10.1007/s11948-021-00315-8.

Fabbri A., Hansen, C., Grundy, Q., Bero, L., Dunn, A. Mohammed, A. & Mintzes, B. (2021). Association between conflicts of interest and authors’ positions on harms of varenicline: a cross-sectional analysis. J Gen Int Med. doi: 10.1007/s11606-021-06915-1.

Grundy, Q., Mazzarello, S., Brennenstuhl, S., & Karanges, E.A. (2021). A comparison of educational events for physicians and nurses in Australia sponsored by opioid manufacturers. PLOS ONE, 16(3): e0248238. doi:10.1371/journal.pone.0248238.

Parker, L., Grundy, Q., Fabbri, A., Mintzes, B. & Bero, L. (2021). “Lines in the sand” - An Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. BMJ Open, 11:e045140. doi: 10.1136/bmjopen-2020-045140.

Traversy, G., Barnieh, E., Akl, E.A., Allan, G.M., Brouwers, M., Ganache, I., Grundy, Q., Guyatt, G.H., Kelsall, D., Leng, G., Moore, A., Persaud, N., Schünemann, H.J., Straus, S., Thombs, B.D., Rodin, R., & Tonelli, M. (2021). Managing conflicts of interest in the development of health guidelines. CMAJ, 193, E49-54. doi: 10.1503/cmaj.200651

Wang, Z. Grundy, Q., & Bero, L. (2021). Understanding professional stakeholders’ active resistance to guideline implementation: The case of Canadian breast screening guidelines. Social Science and Medicine, 269: 113586. doi: 10.1016/j.socscimed.2020.113586.

Grundy, Q., Krasik, O., Meleca, N., Mills, N., Nour, S. & Whalen, E. (2020). Beyond engagement: Realising nurses’ capacity to lead sustainable health systems. Healthcare Papers 19(3), 67-73. doi:10.12927/hcpap.2020.26369

Parker, L., Bennett, A., Mintzes, B., Grundy, Q., Fabbri, A., Karanges, E.A., & Bero, L. (2020). ‘There are ways . . drug companies will get into DTC decisions”: How Australian Drug and Therapeutics Committees address pharmaceutical industry influence. British Journal of Clinical Pharmacology. doi: 10.1111/bcp.14636.

Wang, Z., Grundy, Q., Parker, L. & Bero, L. (2020). Variations in systems for guideline adaptation: A qualitative study of experiences with WHO guidelines. BMC Public Health, 20:1758. doi: 10.1186/s12889-020-09812-0

Grundy, Q., Cussen, C. & Dale, C. (2020). Constructing a problem and marketing solutions: A critical content analysis of the nature and function of industry-authored oral health educational materials. Journal of Clinical Nursing, 29(23-24), 4697-4707. doi: 10.1111/jocn.15510

Grundy, Q., Mazzarello, S. & Bero, L. (2020). A comparison of policy provisions for managing “financial” and “non-financial” interests across health-related research organizations: A qualitative content analysis. Accountability in Research, 27(4): 212-237. doi: 10.1080/08989621.2020.1748015

Grundy, Q., Dunn, A., & Bero, L. (2020). Improving researchers’ conflict of interest declarations. BMJ, 368:m422. doi: 10.1136/bmj.m422.

Grundy, Q., Mayes, C., Holloway, K, Mazzarello, S., Thombs, B. & Bero, L. (2020). Conflict of interest as ethical shorthand: Understanding the range and nature of “non-financial conflicts of interest” in biomedicine. J Clinical Epidemiology, 120: 1-7. doi: 10.1016/j.jclinepi.2019.12.014

Chartres, N., Grundy, Q., Parker, L., & Bero, L. (2020). “It’s not smooth sailing”: Bridging the gap between methods and content expertise in public health guideline development. International J Health Policy & Management.

Bero, L., Chiu, K., & Grundy, Q. (2019). The SSSPIN study—spin in studies of spin: meta-research analysis. BMJ, 367:l6202. doi:10.1136/bmj.l6202.

Parker, L., Fabbri, A., Grundy, Q., Mintzes, B. & Bero, L. (2019). “Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ, 367, l6694. doi: 10.1136/bmj.l6694.

Wang, Z., Grundy, Q., Parker, L., & Bero, L. (2019). Health promoter, advocate, legitimiser — the many roles of WHO guidelines: a qualitative study. Health Research Policy & Systems, 17, 96. doi: 0.1186/s12961-019-0489-z.

Grundy, Q., Chiu, K. & Bero, L. (2019). Commercialization of user data by developers of medicines-related apps. Journal of General Internal Medicine. doi: 10.1007/s11606-019-05214-0.

Grundy, Q. (2019). Choosing Wisely in the context of corporate influence. HealthcarePapers, 18(1), 25-29. doi: 10.12927/hcpap.2019.25872.

Karanges, E. Grundy, Q. & Bero, L. (2019). Understanding the nature and extent of pharmaceutical industry payments to nonphysician clinicians. JAMA Internal Medicine. doi: 10.1001/jamainternmed.2019.1371.

Parker, L., Halter, V., Karliychuk, T., & Grundy, Q. (2019). How private is your mental health data? An empirical study of mental health app privacy policies and practice. International Journal of Law & Psychiatry, 64: 198-204. doi: 10.1016/j.ijlp.2019.04.002.

Grundy, Q., Chiu, K., Held, F., Continella, A., Bero, L. & Holz, R. (2019). Data sharing practices of medicines-related apps: Traffic, network, and content analysis. BMJ, 364: I920. doi: 10.1136/bmj.l920

Parker, L., Bero, L., Gillies, D., Raven, M. & Grundy, Q. (2019). The “hot potato” of mental health app regulation: A critical case study of the Australian policy arena. International Journal of Health Policy and Management, 8(3):168-176. doi: 10.15171/ijhpm.2018.117

Fabbri, A., Lai, A., Grundy, Q., & Bero, L. (2018). The influence of industry sponsorship on the research agenda: A scoping review. American Journal of Public Health, 198(11):e9-e16. doi: 10.2105/AJPH.2018.304677

Parker, L., Bero, L., Gillies, D., Raven, M., Mintzes, B., Jureidini, J., & Grundy, Q. (2018). Mental health messages in prominent mental health apps. Annals of Family Medicine, 16(4), 338-342. doi: 10.1370/afm.2260

Grundy, Q., Hutchison, K., Johnson, J., Blakely, B., Clay-Williams, R., Richards, B. & Rogers, W. (2018). Device representatives in hospitals: Are commercial imperatives driving clinical decision-making? Journal of Medical Ethics, 44:589-592.  doi: 10.1136/medethics-2018-104804

Parker, L., Grundy, Q., & Bero, L. (2018). Interpreting evidence in General Practice: bias and conflicts of interest. The Australian Journal of General Practice, 47(6), 337-340. doi: 10.31128/AJGP-12-17-4432

Grundy, Q., Habibi, R., Shnier, A., Mayes, C., & Lipworth, W. (2018). Decoding disclosure: Comparing conflict of interest policy among France, Australia and the United States. Health Policy, 122(5), 509-518.

Mintzes, B., Swandari, S., Fabbri, A., Grundy, Q., Moynihan, R., & Bero, L. (2018). Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over­active bladder syndrome? An Australian cohort study. BMJ Open, 8: e019027. doi:10.1136/bmjopen-2017-019027

Grundy, Q., Dunn. A.G., Bourgeois, F.T., Coeira, E., & Bero, L. (2018). Prevalence of disclosed conflicts of interest in biomedical research and associations with journal impact factors and Altmetric scores. JAMA, 319(4):408-409. doi:10.1001/jama.2017.20738

Parker, L., Karliychuk, T., Gillies, D., Mintzes, B., Raven, M. & Grundy, Q. (2017). A health app developer's guide to law and policy: A multi-sector policy analysis. BMC Medical Informatics and Decision Making, 17: 141. doi: https://doi.org/10.1186/s12911-017-0535-0

Grundy, Q., Held, F.P., & Bero, L.A. (2017). A social network analysis of the financial links backing health and fitness apps. American Journal of Public Health. doi: 10.2105/AJPH.2017.030995

Grundy, Q., Tierney, L., Mayes, C. & Lipworth, W. (2017). Health professionals "make their choice": Pharmaceutical industry leaders' understandings of conflict of interest. Journal of Bioethical Inquiry, 14(4), 541-553. doi: 10.1007/s11673-017-9804-y

Chiu, K., Grundy, Q., & Bero, L.A. (2017). 'Spin' in published biomedical research: A methodological systematic review. PLoS Biology, 15(9): e2002173. doi: 10.1371/journal/pbio/2002173

Fabbri, A., Grundy, Q., Mintzes, B., Swandari, S., Moynihan, R., Walkom, E. & Bero, L. A. (2017). A cross-sectional analysis of pharmaceutical industry-sponsored events for health professionals in Australia. BMJ Open, 7:e016701. doi: 10.1136/bmjopen-2017-016701

Grundy, Q., Held, F. P., & Bero, L. A. (2017). Tracing the potential flow of consumer data: A network analysis of prominent health and fitness apps. Journal of Medical Internet Research (JMIR), 19(6): e233. doi: 10.2196/jmir.7347

Bero, L. A. & Grundy, Q. (2016). Why having a (non-financial) interest is not a conflict of interest. PLoS Biology, 14(12): e2001221. doi: 10.1371/journal.pbio.2001221

Grundy, Q. (2016). Why marketing to nurses matters. American Nurse Today, 11(11), 28-29, 31

Grundy, Q., Wang, Z. & Bero, L. A. (2016). Challenges in assessing mobile health app quality: A systematic review of prevalent and innovative methods. American Journal of Preventive Medicine. doi: 10.1016/j.amepre.2016.07.009

Grundy, Q., Fabbri, A., Swandari, S., Mintzes, B. & Bero, L. (2016). The inclusion of nurses in pharmaceutical industry-sponsored events: Guess who is also coming to dinner? JAMA Internal Medicine. doi: 10.1001/jamainternmed.2016.5276

Grundy, Q. & Malone, R. E. (2016). The 'as-if' world of nursing practice: Nurses, marketing and decision making. Advances in Nursing Science. 10.1097/ANS.0000000000000143 (full text here)

Grundy, Q. (2016). "Whether something cool is good enough": The role of evidence, sales representatives and nurses' expertise in hospital purchasing decisions. Social Science and Medicine, 165, 82-91. doi: 10.1016/j.socscimed.2016.07.042

Grundy, Q., Bero, L., & Malone, R. E. (2016). Marketing and the most trusted profession: The invisible interactions between registered nurses and industry. Annals of Internal Medicine, 164(11), 733-739. doi:10.7326/M15-2522

Smith, E. A., Grundy, Q., & Malone, R. E. (2015). “It’s not a priority when we're in combat”: Public health professionals and military tobacco control policy. American Journal of Public Health, 105(4), 660-664.

Yonge, O., Myrick, F. & Ferguson, L. & Grundy, Q. (2015). Lessons about boundaries and reciprocity in rural-based preceptorships. Quality Advancement in Nursing Education, 1(2), Article 4. doi: 10.17483/2368-6669.1002

Grundy. Q., Smith, E. A., & Malone, R. E. (2014). “Throwing a rock at their armored tank”: Civilian authority and military tobacco control. BMC Public Health, 14(1292). doi:10.1186/1471-2458-14-1292

Grundy, Q. (2014). “My love-hate relationship”: Ethical issues associated with nurses’ interactions with industry in clinical practice. Nursing Ethics, 21(5), 554-564. doi: 10.1177/0969733013511360

Grundy, Q., Bero, L., & Malone, R. (2013) Interactions between non-physician clinicians and industry: A systematic review. PLoS Medicine, 10(11): e1001561. doi: 10.1371/journal.pmed.1001561

Yonge, O., Myrick F., Ferguson, L., & Grundy, Q. (2013). Multiple lenses: Rural landscape through the eyes of nurse preceptors and students. Journal of Rural and Community Development, 8(1), http://www.jrcd.ca/.

Yonge, O., Myrick, F., Ferguson, L. & Grundy, Q. (2013). “You have to rely on everyone and they on you”: Interdependence and the team-based rural nursing preceptorship. Online Journal of Rural Nursing and Health Care, 13(1).

Yonge, O., Myrick, F., Ferguson, L. & Grundy, Q. (2013). Nursing preceptorship experiences in rural settings: “I would work here for free.” Nurse Education in Practice, 13(2), 125-31. doi: 10.1016/j.nepr.2012.08.001

Grundy, Q. (2012). The Physicians Payments Sunshine Act and the unaddressed role of nurses: An interest group analysis. Policy, Politics & Nursing Practice, 13(3), 154-161. doi: 10.1177/1527154412465196

Malone, R., Grundy, Q., & Bero, L. (2012). Tobacco industry denormalisation as a tobacco control intervention: A review. Tobacco Control, 21(2), 162-170. doi:10.1136/tobaccocontrol-2011-050200

Yonge, O., Myrick, F., Ferguson, L. & Grundy, Q. (2011). Rural Preceptors’ Concerns with Nursing Student Evaluation (Chapter 18). In A. Bushy & D. Molinari (Eds.) Rural Nurse: Transition to Practice. New York, NY: Springer, pp. 207-226.

Luhanga, F., Billay, D., Grundy, Q., Myrick, F., & Yonge, O. (2010).  The one-to-one relationship: Is it really key to an effective preceptorship experience? International Journal of Nursing Education Scholarship, 7(1), Article 21.